Home

Features

  • Unpacking the Latest on Pharma, Trade & Tariffs: What May Be Next?ByPatricia Van Arnum

    Unpacking the Latest on Pharma, Trade & Tariffs: What May Be Next?
    By

    Global volatility on the trade front continued this week as the US put a 90-day pause on implementing its plan for reciprocal tariffs on a country-by-country basis, but uncertainty remains, particularly for certain trading partners, notably China. What is the impact on the pharma industry and what may in store.   


  • Pharma CEOs Speak on the Fallout from Evolving US–EU Trade PolicyByPatricia Van Arnum

    Pharma CEOs Speak on the Fallout from Evolving US–EU Trade Policy
    By

    The European Federation of Pharmaceutical Industries and Associations, representing innovator drug companies in Europe, and Medicines for Europe, representing generics and biosimilars producers in Europe, speak out on  the impact of a changing tariff scheme on the bio/pharma industry in the EU and propose action plans.  


DCAT MEMBER COMPANY COMMUNITY